1. MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells

   • Ulrika W Nilsson
   • Stina Garvin
   • Charlotta Dabrosin

   Preclinical Study 10 October 2006 Pages: 253 - 261

2. 15-Deoxy-Δ^12,14-prostaglandin J₂ inhibits G₂-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression

   • Chinatsu Kamagata
   • Naoki Tsuji
   • Naoki Watanabe

   Preclinical Study 21 September 2006 Pages: 263 - 273

3. AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib

   • Monica R. Maiello
   • Amelia D’Alessio
   • Nicola Normanno

   Preclinical study 27 September 2006 Pages: 275 - 282

4. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients

   • Seeyoun Lee
   • Eun Young Kim
   • Eun Sook Lee

   Clinical Trial 25 October 2006 Pages: 283 - 288

5. Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

   • Jonas Lundkvist
   • Nils Wilking
   • Linus Jönsson

   Clinical Trial 11 October 2006 Pages: 289 - 299

6. Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer

   • N. H. Gordon
   • P. Silverman
   • L. A. Siminoff

   Clinical Trial 11 October 2006 Pages: 301 - 312

7. Pectoral stretching program for women undergoing radiotherapy for breast cancer

   • T.S. Lee
   • S.L. Kilbreath
   • M.J. Lee

   Clinical Trial 02 December 2006 Pages: 313 - 321

8. Changes in risk of death from breast cancer with season and latitude

   • Alina Carmen Porojnicu
   • Zoya Lagunova
   • Johan Moan

   Epidemiology 21 September 2006 Pages: 323 - 328

9. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis

   • Xiang Huo
   • Zhibin Hu
   • Hongbing Shen

   Epidemiology 21 September 2006 Pages: 329 - 337

10. The association between the pre-diagnosis mammography screening interval and advanced breast cancer

    • Anupam Goel
    • Benjamin Littenberg
    • Robert C. Burack

    Epidemiology 23 August 2006 Pages: 339 - 345

11. Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center?

    • Yu Shen
    • Wenli Dong
    • Therese B. Bevers

    Epidemiology 21 September 2006 Pages: 347 - 356

12. Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer

    • M. Kriege
    • C. T. M. Brekelmans
    • J. G. M. Klijn

    Epidemiology 19 October 2006 Pages: 357 - 363

13. Reproductive factors and breast cancer risk among older women

    • Sumitra Shantakumar
    • Mary Beth Terry
    • Marilie D. Gammon

    Epidemiology 11 October 2006 Pages: 365 - 374

14. Results from an observational trial with oral vinorelbine and trastuzumab in advanced breast cancer

    • Rupert Bartsch
    • Catharina Wenzel
    • Guenther G. Steger

    Original Paper 21 September 2006 Pages: 375 - 381